Skip to main content
Yonsei Medical Journal logoLink to Yonsei Medical Journal
. 2022 May 19;63(6):601. doi: 10.3349/ymj.2022.63.6.601

Erratum to “Angiopoietin-1 Modified Human Umbilical Cord Mesenchymal Stem Cell Therapy for Endotoxin-Induced Acute Lung Injury in Rats” by Huang ZW, et al. (Yonsei Med J 2017 Jan;58(1):206–216.)

PMCID: PMC9171663  PMID: 35619585

We would like to replace image of Fig. 4A with new image, for previous image causes some controversy. New images are as follows.

graphic file with name ymj-63-601-g001.jpg

Fig. 4. (A) Histological analysis indicated LPS injection caused capillary vessel engorgement, congestion, abundant inflammatory infiltration in lung stroma (×100). Administration of MSCs or MSCs-Ang1 improved the lung injury at all time points. (B) Lung injury score decreased significantly in the MSCs group and MSCs-Ang1 group at 6 hours, 24 hours, 48 hours, 8 days, and 15 days after LPS injection. (*p<0.05 compared with LPS controls; p<0.05 comparing MSCs-Ang1 with MSCs). Fibroblast injections have no effect on improvement of both pathological morphology and lung injury score. NS, normal saline; LPS, lipopolysaccharide; MSCs, mesenchymal stem cells.


Articles from Yonsei Medical Journal are provided here courtesy of Yonsei University College of Medicine

RESOURCES